title: Response letter regarding the letter to the editors by Brown et al.
authors.affiliation: a GSK Vaccines , Wavre , Belgium.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Taylor
authors.affiliation: a GSK Vaccines , Wavre , Belgium.
authors.forename: Martin
authors.initials: M
authors.lastname: Ryser
authors.affiliation: a GSK Vaccines , Wavre , Belgium.
authors.forename: Attila
authors.initials: A
authors.lastname: Mihalyi
authors.affiliation: a GSK Vaccines , Wavre , Belgium.
authors.forename: Thierry
authors.initials: T
authors.lastname: van Effelterre
mesh_terms: D052161:Human papillomavirus 18 / Q000276:immunology*; D006801:Humans; D030361:Papillomavirus Infections; D053918:Papillomavirus Vaccines; D002583:Uterine Cervical Neoplasms
chemical_list: D053918:Papillomavirus Vaccines
keywords: Cervarix™; HPV; cervical cancer; cross-protection; universal mass vaccination